Skip Ribbon Commands
Skip to main content
Menu
Prof Woo Keng Thye

Prof Woo Keng Thye

​MBBS, FRACP, M Med (Int Med), FAMS

Emeritus Consultant

Emeritus Consultant & Advisor

Singapore General Hospital

Specialty/Department: Renal Medicine

Clinical Interest: Glomerulonephritis

Conditions Treated by this Doctor:
Haemodialysis - Acute and Chronic, Renal Transplant.

Clinical Appointments

  • Emeritus Consultant Renal Medicine Singapore General HospitalSingapore General Hospital

Profile

Professor Woo Keng Thye, MBBS (NUS), M Med, FRACP (Nephrology) was trained at the Royal Melbourne Hospital in Australia. He is Emeritus Consultant and Advisor to Dept of Renal Medicine, SingaporeView More +

Education

Professional Appointments and Committee Memberships

  • ​Head, Dept of Renal Medicine, SGH – 1989 - 2002 
  • Chairman Division of Medicine, SGH – 2000 - 2003 
  • Chairman, Division of Research, SGH – 2001 – 2003 
  • Chairman, Renal Specialist Accreditation Committee – 1998 – 2005 
  • Chairman, National Committee on Renal Care (NCRC) – 1996 – 2005 
  • Chairman, National Medical Research Council (NMRC) 2003 – 2006 
  • Member, National Medical Research Council (NMRC) – 1994 – 2000 
  • Chairman, Medical Clinical Research Committee (MCRC) since 1997 – Present 
  • Member, Medical Clinical Research Committee (MCRC) – 1993 – 1995 
  • Board of Directors – National Kidney Foundation since 2005 – Present 
View More +

Awards

  • Galloway Memorial Lecture 1984 
  • Public Administration Medal (Silver) National Day Award 2002
  • Inaugural Kincaid-Smith Award for Scientific Contribution – 2005
  • 3rd College of Physicians Lecture : Translational Research - 2006
  • Singapore Medical Association (SMA) Lecturer : Physician Leadership – 2007

Research Interests

Publications

Since 1976 he has been involved in research in kidney diseases in the area of Immunology Proteimuria and for past 8 years in Genomics and Proteinuria. Areas of interest include IgA nephritis and other forms of glomerulonephritis. Have focused on drug therapy and clinical trials to retard and prevent renal failure.
  •  K T Woo, B J R Junor, H Salem, A J F d'Apice, J A Whitworth, Priscilla, Kincaid-Smith. Beta-Thromboglobulin and Platelet Aggregates in Glomerulonephritis. Clinical Nephrology, 1980, 14, 9295. 
  • K T Woo, Y O Tan, H K Yap, Y K Lau, C H Lim. Beta-Thromboglobulin in IgA Nephritis. Thrombosis Research, 1982, 24(3), 295-262.
  • K T Woo, Y O Tan, H K Yap, Y K Lau, J S H TAY, C H Lim. Beta-2-Microglobulin in IgA Nephritis. Nephron, 1984, 37 : 78-81.
  • K T Woo, E J C Lee, Y K Lau, C H Lim. Beta-2-microglobulin in the assessment of renal function of the transplanted kidney. Nephron, 1985, 39:223-227.
  • K T Woo, S S Wei, E J C Lee, Y K Lau, C H Lim. The effects of hemodialysis and peritoneal dialysis on antithrombin and platelets. Nephron, 1985, 40:25-28.
  • K T Woo, E J C Lee, Y K Lau, C H Lim. Antithrombin III in IgA Nephritis. Thrombosis Research, 1985, 40:483-487.
  • K T Woo, E J C Lee, Y K Lau, C H Lim. Antithrombin III in Renal Transplant Recipients. Thrombosis Research, 1985, 38:201-206.
  • K T Woo, R P S Edmondson, A Y T Wu, G S C Chiang, H S Pwee, C H Lim. The Natural History of IgA Nephritis in Singapore. Clin Nephrol, 1986, 25:15-21.
  • K T Woo, A Y T Wu, Y K Lau, E J C Lee, R P S Edmondson, H S Pwee, C H Lim. Protein Selectivity in IgA Nephropathy. Nephron, 1986, 42:236-239.
  • K T Woo, R P S Edmondson, H K Yap, A Y T Wu, G S C Chiang, E J C Lee, H S Pwee, C H Lim. Effects on Triple Therapy on the progression of Mesangial Proliferative Glomerulonephritis. Clin Nephrol, 1987, 27:56-64.
  • K T Woo, Y K Lau, H K Yap, G S L Lee, G S C Chiang, C H Lim. Protein Selectivity : A Prognostic Index in IgA nephritis. Nephron 1989, 52:300-306.
  • K T Woo, G S L Lee, Y K Lau, G S C Chiang, C H Lim. Effects of Triple Therapy in IgA Nephritis : A Follow Up Study 5 years later, Clin Nephrol, 1991, 36:60-66.
  • K T Woo, Y K Lau, G S L Lee, S S Wei, C H Lim. Pattern of Proteinuria in IgA Nephritis by SDS-AGE : Clinical Significance. Clin Nephrol, 1991, 36:6-11.
  • K T Woo, Y K Lau, K S Wong, Y M Chin, G S C Chiang, C H Lim. Isoelectric focussing and protein selectivity index as predictors of response to therapy in IgA Nephrotic Syndrome. Nephron, 1994, 67, 408-413
  • KT Woo, YK Lau, GSL Lee, KS Wong, SS Wei, GSC Chiang, CH Lim. Pattern of Proteinuria in IgA Nephropathy, Nephrology 1997; 3, 31 -34.
  • KT Woo, GSC Chiang, AA Pall, PH Tan, YK Lau, YM Chin. The Changing Pattern of Glomerulonephritis in Singapore over the past 2 decades, Clinical Nephrology, 1999, 52, 96 - 102
  • KT Woo, YK Lau, KS Wong, GSC Chiang. ACEI/ATRA Therapy Decreases Proteinuria by Improving Glomerular Permselectivity in IgA Nephritis. Kidney International, 2000, 58, 2485 - 2491
  • KT Woo, YK Lau, Y Zhao, FE Liu, HB Tan, EK Tan, S Fook-Chong, CM Chan, KS Wong. Disease Progression, Response to ACEI/ATRA Therapy and Influence of ACE gene in IgA Nephritis. Cellular & Molecular Biology 2007; 4(3):227-232
  • Woo KT, Chan CM, Choong HL, Tan HK, Foo M, Lee EJC, Tan CC, Lee GSL, Tan SH, Vathsala A, Lim CH, Chiang GSC, Fook-Chong S, Yi Z, Tan HB, Wong KS. High Dose Losartan and ACE gene polymorphism in IgA nephritis. Genomic Medicine, 2009, 2 (3): 77-81. GSL, Tan SH, Lim CH, Chiang GSC, Fook – Chong S, Wong KS.
  • Woo KT, Chan CM, Tan HK, Choong HL, Foo M, Vathsala A, Lee EJC, Tan CC, Lee GSL, Tan SH, Lim CH, Chiang GSC, Fook – Chong S, Wong KS. Beneficial effects of high dose losartan in IgA nephritis. Clinical Nephrol 2009, 71 (6): 617-624
View More +

Research Trials